Augmedix, Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Emmanuel Krakaris
- Full Time Employees
- 1,430
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 111 Sutter Street San Francisco CA United States of America 94104
- IPO Date
- Mar 31, 2021
- CIK
- 0001769804
- Website
- augmedix.com
- Similar Companies
- Business
- Augmedix, Inc. (Nasdaq: AUGX) develops and provides ambient AI-powered medical documentation and data solutions that enable clinicians to focus on patient interactions by automating note generation and administrative tasks for healthcare systems, hospitals, physician practices, and telemedicine providers primarily in the United States. The company offers a suite of products including Augmedix Live, which delivers synchronous real-time medical note documentation and point-of-care support through ambient AI and trained medical documentation specialists; Augmedix Go, an autonomous fully automated AI mobile application for generating notes from recorded visits, including a specialized version for emergency departments developed in partnership with HCA Healthcare; Augmedix Assist, providing asynchronous documentation with AI-drafted notes plus human support for editing, coding, orders, and referrals; and Augmedix Prep, which supplies pre-visit chart preparation with patient demographics, medical history, and medication updates; all integrated with major electronic health records such as Epic, Cerner, Meditech, and athenahealth, supporting 32 languages, real-time care gap reminders via CareCues, and HITRUST-certified HIPAA-compliant security. Founded in 2013 and headquartered at 111 Sutter Street, Suite 1300, in San Francisco, California, Augmedix operates its proprietary Notebuilder Platform leveraging automatic speech recognition, natural language processing, and large language models to transform clinician-patient conversations into structured notes and actionable data insights across specialties like oncology and emergency medicine. In July 2024, Augmedix entered a definitive agreement to be acquired by Commure, Inc. in an all-cash transaction valued at approximately $139 million, or $2.35 per share, positioning it as a wholly-owned subsidiary to accelerate AI innovations, expand integrations, and scale services across more health systems; the deal, expected to close in late 2024 or early 2025 subject to stockholder approval and customary conditions, follows prior name change from Malo Holdings Corporation in October 2020 and builds on collaborations such as with HCA Healthcare for emergency department solutions.
Commure Completes Merger with Augmedix
7 AI Penny Stocks to Watch in October
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Merger and Looming Vote on September 27, 2024, of Augmedix, Inc. - AUGX
Augmedix, Inc. (AUGX) Reports Q2 Loss, Lags Revenue Estimates
Augmedix Delivers 27% Revenue Growth for Second Quarter of 2024
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Augmedix, Inc. – AUGX
Why Is Augmedix (AUGX) Stock Up 150% Today?
Shareholder Alert: Ademi LLP investigates whether Augmedix, Inc. has obtained a Fair Price for its Public Shareholders
Augmedix to Join Forces with Commure
Emergency Services Inc. Partners with Augmedix to Introduce Generative AI Solution That Relieves Clinician Burnout in Emergency Departments
Augmedix Reiterates Second Quarter and Full Year 2024 Outlook
Augmedix Appoints Alex Stinard, M.D., as Chief Clinical AI Officer
Why Is Augmedix (AUGX) Stock Down 41% Today?
Augmedix, Inc. (AUGX) Q1 2024 Earnings Call Transcript
Augmedix Delivers 40% Revenue Growth for First Quarter of 2024
Augmedix to Participate in Upcoming Investor Conferences in May and June 2024
Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments
3 Penny Stocks That Could Make a Big Comeback by the End of Q2
Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide